α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes
Marcela Briššová(Vanderbilt University Medical Center), Alvin C. Powers(Vanderbilt University Medical Center), Fong Cheng Pan(Memorial Sloan Kettering Cancer Center), Shawn Levy(HudsonAlpha Institute for Biotechnology), Gregory Poffenberger(Vanderbilt University Medical Center), Leonard D. Shultz(Jackson Laboratory), May Sanyoura(University of Chicago), Chunhua Dai(Diabetes Australia), Rita Bottino(Children's Hospital of Pittsburgh), J Lindner(Vanderbilt University), David M. Harlan(University of Massachusetts Chan Medical School), Mark A. Atkinson(University of Florida), David M. Blodgett(University of Massachusetts Chan Medical School), Diane C. Saunders(Vanderbilt University Medical Center), Louis H. Philipson(University of Chicago), Shristi Shrestha(Vanderbilt University), Nripesh Prasad(Life Sciences Discovery Fund), Martha Campbell‐Thompson(University of Florida), Matthias G. von Herrath(La Jolla Institute for Immunology), Roland Stein(Vanderbilt University), Dale L. Greiner(University of Massachusetts Chan Medical School), Radhika Aramandla(Vanderbilt University Medical Center), Rachana Haliyur(Vanderbilt University)
Cited by 225
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Human Lymphoid and Myeloid Cell Development in NOD/LtSz- <i>scid IL2R</i> γ <i>null</i> Mice Engrafted with Mobilized Human Hemopoietic Stem Cells,
|The Journal of Immunology|2005|1.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
Production of α1,3-Galactosyltransferase-Deficient Pigs
|Science|2003|1.1k